NATALIE MCDONALD: Open Payments
NPI 1043598055 · SAN ANGELO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$592 in 27 payments from 14 companies in 2025. Trend: 2023 $581 · 2024 $497 · 2025 $592
Food & beverage: $557Education: $35
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 6 | $119 |
| 180 Medical, Inc. | 5 | $107 |
| Astellas Pharma US Inc | 3 | $81 |
| ABBVIE INC. | 3 | $65 |
| AstraZeneca Pharmaceuticals LP | 1 | $35 |
| IMMUNITYBIO, INC. | 1 | $33 |
| Teleflex LLC | 1 | $26 |
| UROGEN PHARMA, INC. | 1 | $24 |
| Sumitomo Pharma America, Inc. | 1 | $23 |
| Boston Scientific Corporation | 1 | $18 |
Products named: ERLEADA, XTANDI, BOTOX, IMFINZI, ANKTIVA, BARRIGEL, Padcev, ORGOVYX.
Industry payments across TX — which companies pay providers there.
